MM Iskandar, the director of Bio Farma, made the statement at the 13th Developing Country Vaccine Manufacturers Networks conference in Bali. The conference, which runs through Friday, is meant to increase the quality and availability of vaccines in developing nations.
“We hope that Bio Farma as the only vaccine manufacturer in Indonesia can be a hub or center for research and development of vaccines and serves as a partner to research new vaccines for developing countries,” Iskandar said.
Iskandar said that regular meetings of vaccine manufacturers in developing countries must occur to encourage the production and distribution of vaccines.
Akira Homma, the president of DCVMN, praised Bio Farma for its vaccine initiatives, particularly its successes with the polio vaccine.
“Bio Farma produces 1.4 billion doses of oral polio vaccine, the biggest in the world,” Homma said.
The success of Bio Farma in creating 11 types of vaccines with world-class recognition has attracted the attention of some partners of the Bill and Melinda Gates Foundation.
The 13th DCVMN meeting received confirmations from more than 100 participants, including representatives from the 14 DCVMN member countries, government officials and vaccine experts from Latin America, Europe, the United States and the United Nations.
“We’ve already received confirmation from 106 participants they will attend the event in Bali,” Rahman Roestan, the corporate secretary of Bio Farma, said.
The member states of the DCVMN include Vietnam, Thailand, South Africa, Republic of Korea, Republic of China, Mexico, Iran, Indonesia, India, Egypt, Cuba, Brazil, Bangladesh and Argentina.